Studies on Several Genetic Hematologic Characteristics of the Mexican Population: IV. The Finding of a Fast Hemoglobin Component (Hemoglobin Mexico) in an Indian Family

The clinical, genetic and electrophoretic characteristics of what is verylikely a new hemoglobin variant, hemoglobin Mexico, are presented. It isclinically silent, transmitted by an autosomal co-dominant gene, and inalkaline pH moves faster than hemoglobin A.

Submitted on January 9, 1963 Accepted on April 21, 1963     

Relationship between European Mitochondrial Haplogroups and Chronic Renal Allograft Rejection in Patients with Kidney Transplant

Mitochondrial DNA variants may contribute to differences in mitochondrial function, leading to an altered immune system. The aim of this study was to analyze the relationship between mtDNA haplogroups and the development of chronic allograft dysfunction in patients with kidney transplant. A retrospective observational study was carried out on 261 patients who received kidney transplant (114 had stable transplant and 147 patients developed chronic allograft dysfunction). DNA samples were genotyped for 14 mtDNA polymorphisms by using Sequenom''s MassARRAY platform (San Diego, CA, USA). Only European white patients within the N macro-cluster were included. Patients with haplogroups V (odds ratio (OR)=0.32; p=0.037) and J (OR=0.36; p=0.038) showed lower odds for developing CRAD than patients with haplogroup H. After adjusting for the most significant variables, haplogroups V and J tended to statistical significance (p=0.091 and p=0.067 respectively). This is a preliminary study in which mtDNA haplogroups seem to be implicated in susceptibility or protection for developing chronic allograft dysfunction.     

Alternating Wenckebach Periods in Acute Inferior Myocardial Infarction: Clinical, Electrocardiographic, and Therapeutic Characterization

We report on twelve patients with alternating Wenckebach periods (AWP) occurring during an acute inferior myocardial infarction (AIMI). There were nine males and three females, with a mean age of 61 years (range, 43 to 75). AWP appeared during the first 48 hours of the AIMI in 10 patients and on the fourth day of hospitalization in two patients. AWP occurred spontaneously in nine patients and following the administration of atropine in the remaining three patients. Mean systolic blood pressure significantly decreased during AWP as compared to the period preceding or following the bradyarrhythmia (93 ± 42 mmHg vs 123 ± 37 mmHg, p < 0.02). Killip functional class was significantly higher during AWP as compared to the period preceding or following the bradyarrhythmia (2.1 ± 1.2 vs 1.5 ± 0.8, p < 0.02). Pacemaker therapy was initiated prophylactically in two patients, because of syncope in six, because of hemodynamic deterioration in two, and for syncope and hemodynamic deterioration in two. Three patients died in cardiogenic shock despite pacemaker therapy. No evidence of right ventricular infarction was seen in the patients.
Atropine administration during AWP significantly increased the sinus rate and significantly decreased the ventricular rates and the systolic blood pressure. In addition, three patients developed long bouts of paroxysmal AV block. Isoproterenol administration improved AV conduction in one patient, caused no change in two patients and induced non-sustained ventricular tachycardia in three patients.
In conclusion, AWP occurring during AIMI is a symptomatic bradyarrhythmia associated with hemodynamic deterioration. Drug therapy for this bradyarrhythmia is usually ineffective and sometimes paradoxical responses are observed. Pacemaker therapy is usually needed to correct symptoms and the worsening hemodynamic status. We recommend prophylactic pacemaker implantation in patients developing AWP during AIMI.     

Hairy pigmented congenital naevocellular naevus in a patient with alopecia universalis

We describe a patient with universal alopecia of 8 years duration, and an alopecia-resistant hairy pigmented congenital naevocellular naevus on the scalp.